DavidCherney TorontoCanada

Dr. Cherney is currently Professor of Medicine and Gabor Zellerman Chair of Nephrology Research, University of Toronto. He is a Clinician Scientist in the Division of Nephrology at the University Health Network and Mount Sinai Hospitals and Director of the Renal Physiology Laboratory at UHN. He is supported by the Canadian Institutes of Health Research, the Kidney Foundation of Canada, the JDRF, the Heart and Stroke Richard Lewar Centre of Excellence, and the Heart and Stroke Foundation of Canada, and is the recipient of a 5-year combined CIHR-KFOC Team Grant-JDRF Operating Grant in diabetic kidney disease related to type 1 diabetes (2022-2027). He is also supported by a Department of Medicine, University of Toronto Merit Award. Dr. Cherney’s research program focuses on physiological factors that initiate renal disease in patients with diabetes, such as renal hyperfiltration and inflammation, and the role of the cardiorenal axis in diabetes. His research group is also involved in early and late phase clinical trials in the cardiorenal-metabolic field, including several primary renal outcome trials in patients with and without diabetes. Dr. Cherney’s research program is closely aligned with his integrated and multidisciplinary cardiac-renal-endocrine clinic at the University Health Network, which maintains a strong emphasis on the prevention of diabetic nephropathy and cardiovascular disease. In 2019, he received the American Society of Nephrology (ASN) Distinguished Researcher Award for outstanding contributions to nephrology. In 2019 he also received the Diabetes Canada/CIHR - Institute of Nutrition Diabetes and Metabolism (INMD) Young Scientist Award. In the 2024, Dr. Cherney was the recipient of the Eaton Scholar Researcher of the Year Award, University of Toronto.